We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · December 04, 2021

Risk of De Novo Psoriasis in Hypertension Patients Initially Treated With Beta-Blockers

Journal of the European Academy of Dermatology and Venereology: JEADV

 

Additional Info

Journal of the European Academy of Dermatology and Venereology: JEADV
Risk of de novo psoriasis in hypertension patients initially treated with beta-blockers: Nationwide population-based cohort study in Korea
J Eur Acad Dermatol Venereol 2021 Oct 09;[EPub Ahead of Print], YE Kim, Y Cho, SJ Jo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading